Proteomic insights into SARS-CoV-2 infection mechanisms, diagnosis, therapies and prognostic monitoring methods
S Yu, X Li, Z Xin, L Sun, J Shi - Frontiers in Immunology, 2022 - frontiersin.org
At the end of 2019, the COVID-19 pandemic, caused by severe acute respiratory syndrome
coronavirus type 2 (SARS-CoV-2) infection, seriously damaged world public health security …
coronavirus type 2 (SARS-CoV-2) infection, seriously damaged world public health security …
Discovery of potential therapeutic drugs for covid-19 through logistic matrix factorization with kernel diffusion
X Tian, L Shen, P Gao, L Huang, G Liu, L Zhou… - Frontiers in …, 2022 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is rapidly spreading. Researchers around the world
are dedicated to finding the treatment clues for COVID-19. Drug repositioning, as a rapid …
are dedicated to finding the treatment clues for COVID-19. Drug repositioning, as a rapid …
Analyzing host-viral interactome of SARS-CoV-2 for identifying vulnerable host proteins during COVID-19 pathogenesis
The development of therapeutic targets for COVID-19 relies on understanding the molecular
mechanism of pathogenesis. Identifying genes or proteins involved in the infection …
mechanism of pathogenesis. Identifying genes or proteins involved in the infection …
SARS-CoV-2 ORF8 dimerization and binding mode analysis with class I MHC: computational approaches to identify COVID-19 inhibitors
SARS-CoV-2 encodes eight accessory proteins, one of which, ORF8, has a poorly
conserved sequence with SARS-CoV and its role in viral pathogenicity has recently been …
conserved sequence with SARS-CoV and its role in viral pathogenicity has recently been …
[HTML][HTML] Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma …
Abstract Background Pathogenic coronaviruses include Middle East respiratory syndrome
coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), and …
coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), and …
Natural products database screening for the discovery of naturally occurring SARS‐Cov‐2 spike glycoprotein blockers
SARS‐CoV‐2 coronavirus has been recognized the causative agent of the recent and
ongoing pandemic. Effective and specific antiviral agents or vaccines are still missing …
ongoing pandemic. Effective and specific antiviral agents or vaccines are still missing …
DRaW: prediction of COVID-19 antivirals by deep learning—an objection on using matrix factorization
SM Hashemi, A Zabihian, M Hooshmand… - BMC …, 2023 - Springer
Background Due to the high resource consumption of introducing a new drug, drug
repurposing plays an essential role in drug discovery. To do this, researchers examine the …
repurposing plays an essential role in drug discovery. To do this, researchers examine the …
Essential interpretations of bioinformatics in COVID-19 pandemic
The currently emerging pathogen SARS-CoV-2 has produced the global pandemic crisis by
causing COVID-19. The unique and novel genetic makeup of SARS-CoV-2 has created …
causing COVID-19. The unique and novel genetic makeup of SARS-CoV-2 has created …
IBD systems biology is here to stay
C Fiocchi, D Iliopoulos - Inflammatory bowel diseases, 2021 - academic.oup.com
Background Systems biology is a rapidly advancing field of science that allows us to look
into disease mechanisms, patient diagnosis and stratification, and drug development in a …
into disease mechanisms, patient diagnosis and stratification, and drug development in a …
Present and future treatment strategies for coronavirus disease 2019
E Elekhnawy, AA Kamar, F Sonbol - Future journal of pharmaceutical …, 2021 - Springer
Background The recent pandemic of coronavirus disease 2019 (COVID-19) has resulted in
many challenges to the healthcare organizations around the world. Unfortunately, until now …
many challenges to the healthcare organizations around the world. Unfortunately, until now …